Market Tracker

04/17 6:05pm ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

64.17
Data as of Apr 17
 -0.22 / -0.34%
Today’s Change
51.96
Today|||52-Week Range
89.96
-13.63%
Year-to-Date

Today’s Trading

Previous close64.39
Today’s open64.18
Day’s range63.42 - 65.68
Volume1,278,850
Average volume (3 months)1,669,280
Market cap$15.5B
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-296.00%
Earnings growth (this year)-17.88%
Earnings growth (next 5 years)+32.55%
Revenue growth (last year)-20.63%
P/E ratioNM
Price/Sales13.79
Price/Book11.32

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.07+0.25%
MYLMylan Inc-0.29-0.61%
PRGOPerrigo Company PLC-1.33-0.93%
ENDPEndo International P...-0.44-0.76%
Data as of 4:02pm ET, 04/17/2014

Financials

Next reporting dateMay 2, 2014
EPS forecast (this quarter)-$0.71
Annual revenue (last year)$1.2B
Annual profit (last year)-$445.0M
Net profit margin-36.72%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeff M. Leiden
Chief Financial Officer &
Executive Vice President
Ian F. Smith
Corporate headquarters
Cambridge, Massachusetts

Forecasts